Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in DSGN — Design Therapeutics, Inc.

CIK 1179392 NEW YORK, NY
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$476,424
+$302,992 QoQ
Shares Held
32,925
+102.0% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 136 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. DSGN ranks #250 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 1,875,937 $564,713,315
2 MRNA
Moderna, Inc.
 7,193,530 $503,762,905
3 IONS
Ionis Pharmaceuticals Inc
 6,252,342 $495,748,197
4 REGN
Regeneron Pharmaceuticals, Inc.
 656,124 $409,119,558
5 BBIO
BridgeBio Pharma, Inc.
 4,722,185 $351,708,338
6 EXEL
Exelixis, Inc.
 4,209,861 $229,058,537
7 INCY
Incyte Corp
 2,003,559 $227,123,448
8 ARGX
Argenx SE
 185,638 $172,229,367

All Filings in DSGN

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $476,424 32,925
2026-03-31 $173,432 16,300
2025-12-31 $433,703 46,237
2025-09-30 $446,054 59,237
2025-06-30 $300,978 89,311
2025-03-31 $496,963 128,747
2024-12-31 $1,258,254 203,931
2024-09-30 $1,636,832 304,244
2024-06-30 $1,349,095 402,715
2024-03-31 $1,700,801 422,035
2023-12-31 $1,134,653 428,171
2023-09-30 $150,650 63,835
2023-06-30 $729,426 115,782
2023-03-31 $1,033,383 179,096
2022-12-31 $360,054 35,093